![Christopher Beck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Beck is Senior Vice President-Operations at Context Therapeutics, Inc. since 2022.
Former positions include Vice President-Program Management at Galera Therapeutics, Inc., Aevi Genomic Medicine, Inc., and Formular Pharmaceuticals, Inc. Education includes an undergraduate degree from Drexel University and an MBA from The Pennsylvania State University.
| Sociétés | Poste | Début |
|---|---|---|
| CONTEXT THERAPEUTICS INC. | Directeur des opérations | 05/01/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| AEVI GENOMIC MEDICINE, INC. | Corporate Officer/Principal | - |
Formular Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
| GALERA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 6 |
|---|---|
Galera Therapeutics, Inc.
 Galera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs to reduce normal tissue toxicity from radiotherapy | Health Technology |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aevi Genomic Medicine, Inc.
 Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of treatments for auto-immune pediatric disease | Health Technology |
Context Therapeutics, Inc.
 Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
Formular Pharmaceuticals, Inc. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
